Cargando…
Chemical Conjugation of Evans Blue Derivative: A Strategy to Develop Long-Acting Therapeutics through Albumin Binding
The efficacy of therapeutic drugs is highly dependent on their optimal in vivo pharmacokinetics. Albumin conjugation is considered to be one of the most effective means of protracting the short lifespan of peptides and proteins. In this study, we proposed a novel platform for developing long lasting...
Autores principales: | Chen, Haojun, Wang, Guohao, Lang, Lixin, Jacobson, Orit, Kiesewetter, Dale O., Liu, Yi, Ma, Ying, Zhang, Xianzhong, Wu, Hua, Zhu, Lei, Niu, Gang, Chen, Xiaoyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729772/ https://www.ncbi.nlm.nih.gov/pubmed/26877782 http://dx.doi.org/10.7150/thno.14322 |
Ejemplares similares
-
Evans Blue Attachment Enhances Somatostatin Receptor Subtype-2 Imaging and Radiotherapy
por: Tian, Rui, et al.
Publicado: (2018) -
SUN-118 Somatostatin Agonist Conjugated to the Evans Blue Moiety Is a Superior Analog in the Diagnosis and Treatment of Tumors Characterized by High Somatostatin Receptor Expression
por: Thakur, Shilpa, et al.
Publicado: (2020) -
Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics
por: Wen, Xuejun, et al.
Publicado: (2022) -
Quantification of Tumor Vascular Permeability and Blood Volume by Positron Emission Tomography
por: Chen, Haojun, et al.
Publicado: (2017) -
“Albumin Hitchhiking” with an Evans Blue Analog for Cancer Theranostics
por: Ehlerding, Emily B., et al.
Publicado: (2018)